Is IMAX a Buy? What to Consider in 2026

Short answer

The bull case for IMAX Corporation (IMAX) rests on Record box office and premium share: IMAX posted its highest-grossing year ever in 2025 with about $1.28 billion in global box office, up 40% year over year, and indexed roughly a 15% share of premium film releases on opening weekends. Revenue (FY2025) is ~$410 million (+16%). If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: IMAX's results depend heavily on the theatrical film release calendar, which it does not control, so a weak slate of major titles in any period can pressure box office and revenue. Whether IMAX is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.

IMAX Corporation designs and markets premium large-format cinema systems and licenses proprietary technology that lets studios remaster films into the IMAX format. Rather than owning most theaters itself, IMAX runs an asset-light model: it sells or leases its projection and sound systems to exhibitor partners, then earns ongoing revenue tied to ticket sales through revenue-share and joint-venture arrangements. Its two reporting segments are Technology Products and Services (the systems, maintenance, and network operations) and Content Solutions (film remastering, distribution, and the growing slate of local-language titles). By 2025 the IMAX network spanned more than 1,700 theaters globally, larger than rival premium formats. The investment picture rests on premium cinema outperforming the broader box office as audiences pay up for a differentiated experience. In full-year 2025 IMAX reported best-ever revenue of about $410 million, up 16%, alongside a record global IMAX box office of roughly $1.28 billion and record cash from operations near $127 million. Growth drivers include an expanding local-language film slate (led by titles from China, Japan, and India), record system installations and signings, and margin expansion in Content Solutions. Offsetting these are the company's dependence on a strong Hollywood release calendar, a volatile Greater China market that dropped sharply in early 2026, rising competition from other premium formats, and a valuation that leaves little room for disappointment.

What's the case for buying IMAX?

1. Record box office and premium share.

IMAX posted its highest-grossing year ever in 2025 with about $1.28 billion in global box office, up 40% year over year, and indexed roughly a 15% share of premium film releases on opening weekends. Its 2026 guidance calls for approximately $1.4 billion in global box office, which would set another record. Because IMAX earns a revenue share on tickets, box-office strength flows directly to its top line.

2. Local-language content expansion.

IMAX's local-language box office reached about $405 million in 2025, some 66% above the prior record, as films from China, Japan, and India traveled further than before. The company expects to grow its local-language slate to around 75 titles in 2026 from 67 in 2025. This diversifies IMAX away from sole reliance on the Hollywood tentpole calendar and opens content supply in more markets.

3. Network growth: installations and signings.

IMAX installed 160 systems in 2025 at the high end of guidance and signed 166 new systems, up 28% from 2024, and guides to 160 to 175 installations in 2026. It is pushing an Asia-Pacific expansion strategy across India, Japan, Australia, and Southeast Asia. Each new system widens the network that generates recurring, box-office-linked revenue.

4. Margins and cash generation.

Content Solutions margin expanded from 53% in 2024 to 66% in 2025, and the company reported a record adjusted EBITDA margin near 45% with cash from operating activities up 79% to about $127 million. The asset-light licensing model means incremental box-office dollars carry high margins. Management frames recent margin and cash headwinds as deliberate investments to accelerate future growth.

What are the risks to IMAX?

IMAX's results depend heavily on the theatrical film release calendar, which it does not control, so a weak slate of major titles in any period can pressure box office and revenue. Greater China is a swing market: IMAX box office there plunged roughly 62% in the first quarter of 2026 against a very strong prior-year period, showing how concentrated and volatile that geography can be. Competition from Dolby Cinema, Cinemark XD, Regal RPX, ScreenX, 4DX, and exhibitors' own premium-format brands is intensifying, and some operators resent the revenue cut IMAX takes. Longer term, the shift toward streaming and shorter theatrical windows could erode moviegoing, and at a trailing price-to-earnings multiple around 60x the stock prices in continued record performance, leaving it exposed if growth slows.

How is IMAX valued? (as of FEBRUARY 2026)

Price

$38.13

Market cap

$2.10B

P/E (TTM)

56.91

Forward P/E

19.55

Price / book

6.24

Beta

0.37

52-week range

$24.20 to $45.52

Snapshot for IMAX as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

Revenue (FY2025): ~$410 million (+16%)
Net income margin: ~11%
Adjusted EBITDA margin: ~45% (record)
Global IMAX box office (2025): ~$1.28 billion (record)
Cash from operations: ~$127 million (+79%)
Market cap: ~$2.2 billion
P/E (trailing): ~60x
2026 box-office guidance: ~$1.4 billion

As of February 2026, IMAX reported best-ever full-year 2025 revenue of about $410 million with a net income margin near 11%, and the stock traded around the high $30s for a market cap near $2.2 billion. The trailing price-to-earnings multiple of roughly 60x is high relative to the broader market, reflecting expectations for continued record box office and network growth. The 2026 guidance of about $1.4 billion in global box office and 160 to 175 installations frames the growth the valuation assumes.

How do you decide if IMAX is a buy?

Rather than asking whether IMAX is a buy in the abstract, it tends to help to answer four questions:

Thesis: do you believe the case above, and is it still true today?
Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
Overlap: check whether you already hold IMAX indirectly through an index or sector ETF before adding more.

For the full picture, see the IMAX stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about IMAX against your real portfolio and see your actual exposure before deciding.

The bottom line on IMAX

The bottom line: IMAX Corporation's story right now is Record box office and premium share, with revenue (fy2025) at ~$410 million (+16%). If you believe that narrative continues, the call is about sizing IMAX sensibly and checking overlap with what you own; if you doubt it (the risk: iMAX's results depend heavily on the theatrical film release calendar, which it does not control, so a weak slate of major titles in any period can pressure box office and revenue.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.

Build a basket around IMAX with Walnut

Use IMAX Corporation as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

Create a free Walnut account

FAQ

Is IMAX a good stock to buy right now?

The case for IMAX Corporation right now is Record box office and premium share, with revenue (fy2025) at ~$410 million (+16%). If you believe that thesis holds, IMAX is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is iMAX's results depend heavily on the theatrical film release calendar, which it does not control, so a weak slate of major titles in any period can pressure box office and revenue. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.

What does IMAX Corporation do?

IMAX Corporation designs and markets premium large-format cinema systems and licenses proprietary technology that lets studios remaster films into the IMAX format.

What are the main risks of IMAX?

What does IMAX Corporation actually do?

IMAX designs premium large-format cinema systems and licenses proprietary projection, sound, and film-remastering technology to theater operators worldwide. It runs an asset-light model, earning revenue from selling or leasing systems and from a share of the box office on films shown in the IMAX format.

Is IMAX a real operating company or a speculative stock?

IMAX is a long-established, profitable operating company listed on the NYSE. It reported best-ever revenue of about $410 million in full-year 2025 with a net income margin near 11% and a network of more than 1,700 theaters globally, so it is a real business rather than a speculative shell.

How does IMAX make money?

IMAX earns money two main ways: selling, leasing, and maintaining its cinema systems (the Technology Products and Services segment) and remastering plus distributing films while taking a share of ticket sales (the Content Solutions segment). Its results scale with both the number of installed systems and how strong the film box office is.

How did IMAX perform in 2025?

IMAX posted best-ever revenue of about $410 million, up 16%, alongside a record global IMAX box office near $1.28 billion, record cash from operations around $127 million, 160 system installations, and 166 signings. Content Solutions margin expanded from 53% to 66% year over year.

Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell IMAX; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.